Wugen to Present at the Upcoming Jefferies Cell & Genetic Medicine Summit

ST. LOUIS & SAN DIEGO–(BUSINESS WIRE)–Wugen, Inc., a clinical-stage biotechnology company developing a pipeline of allogeneic cell therapies to treat a broad range of hematological and solid tumor malignancies, today announced that management will participate in a fireside chat at 1:30 p.m. ET on Friday, September 30, 2022 at the upcoming Jefferies Cell & Genetic Medicine Summit set to take place in New York City. About Wugen Wugen, Inc., is a clinical-stage biotechnology company developi
Click here to view original post